Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The VitamIn C, HydrocorTisone and ThiAMINe in Patients With Septic Shock Trial (VITAMINS Trial) - A Prospective, Feasibility, Pilot, Multi-centre, Randomised, Open-label Controlled Trial

NCT03333278 is registered in ClinicalTrials.gov with Australian and New Zealand Intensive Care Research Centre as lead sponsor.

NCT NCT03333278
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03333278 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The VitamIn C, HydrocorTisone and ThiAMINe in Patients With Septic Shock Trial (VITAMINS Trial) - A Prospective, Feasibility, Pilot, Multi-centre, Randomised, Open-label Controlled Trial
Lead sponsor
Australian and New Zealand Intensive Care Research Centre
Phase
Phase 2
Overall status
Completed
Start date
May 2, 2018
Completion date
October 6, 2019
Enrollment
216 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

critically ill, sepsis, shock, septic, vasoplegic syndrome